Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Plain Language Summary
# Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (HR 842) **What it would do:** This bill would allow Medicare to cover and pay for multi-cancer early detection screening tests starting in 2028. These are newer blood tests that can screen for multiple types of cancer at once. The tests would only be covered if the FDA approves them and if Medicare's administrators determine coverage is appropriate. The coverage would be limited to people under a certain age (starting at age 68 in 2028, then increasing by one year annually) and patients could receive one test every 11 months. **Who it affects:** The bill primarily affects Medicare beneficiaries, the federal health insurance program for people 65 and older.
It also impacts medical companies developing multi-cancer screening tests, which could see increased demand if Medicare coverage begins. Taxpayers would bear the cost of expanded Medicare benefits, though the bill delays implementation until 2028. **Current status:** HR 842 was introduced by Rep. Jodey Arrington (R-TX) in the 119th Congress and is currently in committee, meaning it has not yet been voted on by the full House of Representatives. It remains in the early stages of the legislative process.
CRS Official Summary
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage ActThis bill allows, beginning in 2028, for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate. Coverage is limited to those under a certain age (age 68 in 2028, increased by one year every year thereafter) and to one test every 11 months.
Latest Action
Reported (Amended) by the Committee on Ways and Means. H. Rept. 119-333, Part I.